Search Results
Jul 20, 2026, 07:30 ET Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload
ongoing Phase 1 dose-escalation trial in unselected patients with advanced urothelial cancer, head and neck squamous cell carcinoma, and non-small cell lung cancer who have failed standard-of-care therapy, as well as other tumor types harboring FGFR3 genomic alterations. Biohaven plans to initiate combination
More news about: Biohaven Ltd.
Jul 20, 2026, 07:00 ET CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights
blood pumps already in the hospital (e.g. dialysis, continuous renal replacement therapy or CRRT, extracorporeal membrane oxygenation or ECMO, and heart-lung machines), where blood is repeatedly recirculated outside the body, through our cartridges where toxic substances are removed, and then back into the
More news about: Cytosorbents Corp
Jul 20, 2026, 03:00 ET Antengene Announces Poster Presentation of ATG-022 and ATG-037 at ESMO 2026
documents subsequently submitted to the Hong Kong Stock Exchange.For more information, please contact:Investor Contacts: Donald LungE-mail: [email protected] BD Contacts:Ariel
More news about: Antengene Corporation Limited
Jul 20, 2026, 01:32 ET Akeso Doses First Patient in Phase II Study of Novel TROP2/Nectin-4 Bispecific ADC (AK146D1) in Combination with Ivonescimab for Advanced NSCLC
antibody-drug conjugate (ADC), AK146D1, in combination with ivonescimab (the Company's PD-1/VEGF bispecific antibody) in patients with advanced non-small cell lung cancer (NSCLC). The study will explore the therapeutic potential of this combination, with a particular emphasis on the first-line treatment setting.
More news about: Akeso, Inc.
Jul 17, 2026, 11:58 ET AAF Recommends Midwest, East Coast Residents and Businesses Upgrade to MERV 13-rated Air Filters in Wildfire-Impacted Regions
EPA identifies children, older adults and people with existing heart or lung conditions as facing the greatest risk.Research from
More news about: AAF International
Jul 17, 2026, 09:00 ET IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs
Pharma, will also present clinical trial results from their Phase 1 study of IDE849 (SHR-4849) being conducted in China in patients with small cell lung carcinoma (SCLC) and other neuroendocrine carcinomas (NECs).
More news about: IDEAYA Biosciences, Inc.
Jul 17, 2026, 08:00 ET SystImmune Announces Second Approval of Iza-bren in China for the Treatment of Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
types."Iza-bren is currently being evaluated in multiple global clinical studies across several solid tumor indications, including non-small cell lung cancer, breast cancer, urothelial cancer, and other EGFR/HER3-expressing malignancies.About PANKU-Esophagus01PANKU-Esophagus01
More news about: SystImmune, Inc.
Jul 16, 2026, 12:08 ET In HelloNation, Expert Veterinarian Dr. Margaret Koosmann Discusses the Importance of Preventive Veterinary Care
scheduling a routine pet wellness exam. During each pet wellness exam, veterinarians evaluate overall health, including weight, body condition, heart and lung function, mobility, skin, eyes, ears, and dental health. Even healthy-looking pets can have underlying medical issues, making regular examinations an
More news about: HelloNation
Jul 16, 2026, 10:30 ET Oligonucleotide Synthesis Market worth $32.72 billion by 2031 - Exclusive Report by MarketsandMarkets™
Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030
More news about: MarketsandMarkets
Jul 16, 2026, 09:20 ET Barry Manilow Returns to the International Theater with Three Sold-Out Performances at Westgate Las Vegas
my home away from home."Manilow announced in December that he would be postponing performances to undergo surgery after being diagnosed with lung cancer. His return this week marked an emotional milestone for both the performer and the generations of fans who have followed his extraordinary career."Seeing
More news about: Westgate Las Vegas Resort & Casino
Jul 16, 2026, 09:12 ET Bitmine Immersion Technologies (BMNR) Công Bố Thông Điệp Tháng 7 từ Chủ Tịch: "ETH là liều thuốc cho 'Thung Lũng Kỳ Lạ của Sự Giàu Có'"
định hướng tập trung tích lũy tiền mã hóa để đầu tư dài hạn, hôm nay công bố Thông Điệp Tháng 7 từ Chủ Tịch với tiêu đề "ETH là liều thuốc cho 'Thung Lũng Kỳ Lạ của Sự Giàu Có'."
More news about: Bitmine Immersion Technologies, Inc.
Jul 16, 2026, 09:00 ET Priority Health Collaborates With GRAIL as the First Michigan Health Plan to Offer the Galleri® Multi-Cancer Early Detection Blood Test to Employer Plans
and should be used in addition to recommended cancer screenings such as mammography, colonoscopy, prostate-specific antigen (PSA) test, cervical or lung cancer screening. The Galleri test is recommended for adults with an elevated risk for cancer, such as those aged 50 or older.For more information,
More news about: GRAIL, Inc.
Jul 16, 2026, 07:30 ET Galmed Announces the Breakthrough Development of Novel LNP Cardiac Targeted Formulation of its SCD1 inhibitor, Aramchol
2025.Aramchol's anti-fibrotic effects were demonstrated in the liver in a Phase 3 (open label part) MASH study as well as in human heart organoids and in-vivo lung and heart models.Traditional Aramchol formulation results in 80-90% accumulation in the liver and has limited effect on the heart. The new
More news about: Galmed Pharmaceuticals Ltd.
Jul 16, 2026, 07:00 ET Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Patients with Pulmonary Arterial Hypertension
differentiated prostanoid being evaluated as a once-daily therapy for the treatment of patients with PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD), progressive pulmonary fibrosis (PPF), and idiopathic pulmonary fibrosis (IPF). TPIP is administered in a capsule-based inhalation
More news about: Insmed Incorporated
Jul 15, 2026, 10:31 ET Soft Tissue Sarcoma Market Set for Significant Growth at a CAGR of 7.9% During the Forecast Period (2026-2036), Driven by Novel Therapies and Expanding Treatment Landscape | DelveInsight
Soft Tissue Sarcoma with Lung Metastases MarketSoft Tissue Sarcoma with Lung Metastases Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding
More news about: DelveInsight Business Research, LLP
Jul 15, 2026, 09:57 ET Hope with EAPs: 3 Things to Know About Expanded Access Programs for People with No Other Treatment Options
Lung.org/EAP.About the American Lung AssociationThe American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic
More news about: American Lung Association
Jul 15, 2026, 09:00 ET TytoCare Names Adam Pellegrini as CEO and Closes $25M+ Growth Round to Scale AI-First Clinical Enablement Platform
wide.TytoCare's platform combines a handheld examination platform featuring FDA-cleared medical devices — capable of capturing clinical-grade heart, lung, ear, skin, throat, and abdomen data — with a suite of FDA-cleared AI-powered SaMD algorithms that enable clinicians to conduct comprehensive remote
More news about: TytoCare
Jul 14, 2026, 20:00 ET 全球首個ADC+IO對比免疫聯合化療一線治療PD-L1陰性非鱗狀NSCLC III期研究達到主要終點，蘆康沙妥珠單抗聯合帕博利珠單抗有望重塑治療格局
作為頭對頭對比一線標準治療「免疫+化療」的III期臨床研究，OptiTROP-Lung06證實了以蘆康沙妥珠單抗(sac-TMT)替代傳統培美曲塞/鉑類化療具有顯著優勢——蘆康沙妥珠單抗(sac-TMT)聯合帕博利珠單抗對比帕博利珠單抗聯合培美曲塞及鉑類化療，PFS顯著延長並觀察到OS積極獲益趨勢聚焦一線治療更具挑戰性的PD-L1陰性非鱗狀NSCLC人群，在PD-1單抗的基礎上引入TROP2 ADC，不僅發揮了ADC精準靶向殺傷的作用，更通過協同效應激活了免疫微環境，有望釋放PD-1單抗在PD-L1陰性/免疫應答不足人群中的潛力，打破該人群的治療瓶頸繼一線治療PD-L1陽性NSCLC的
More news about: 科倫博泰
Jul 14, 2026, 19:30 ET Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint
registrational OptiTROP-Lung05 study of sac-TMT in combination with pembrolizumab as first-line treatment for PD-L1-positive NSCLC had successfully met its primary endpoint, supporting the submission of a new indication application to the CDE. The findings of the OptiTROP-Lung05 study were presented as
More news about: Kelun-Biotech
Jul 14, 2026, 18:04 ET Has Anyone Tried Gundry MD Phyto Collagen Complex? Read Real Reviews, Ingredients, and Benefits
cardiothoracic surgeons before leaving his practice to pursue restorative medicine. Today, he is the founder and medical director of The International Heart and Lung Institute and The Centers for Restorative Medicine in Palm Springs and Montecito, California, where he has spent the past 25 years helping people restore
More news about: Gundry MD
Jul 14, 2026, 16:52 ET Public Health Groups, Pediatricians and Parents Sue FDA Over Policy Allowing the Marketing of Unauthorized E-Cigarettes and Nicotine Pouches
Campaign for Tobacco-Free Kids, American Academy of Pediatrics, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, Truth Initiative, Parents Against Vaping, a pediatrician with expertise in adolescent tobacco use, and a parent of two children who became
More news about: Campaign for Tobacco-Free Kids
Jul 14, 2026, 15:05 ET Legionnaires' Disease Lawyers Retained to Investigate Upper East Side Legionnaires' Disease Outbreak
who inhale water vapor from Legionella-contaminated cooling towers can develop Legionnaires' disease. Especially if they are over 50 years old, have lung problems, have cancer, or are immunocompromised.Is Legionnaires' Disease Preventable?Yes, Legionnaires' disease is preventable.
More news about: The Lange Law Firm
Jul 14, 2026, 08:35 ET Pickleball Kingdom Centerville to Host the Jovante Woods Foundation Celebrity Pickleball Showcase on Sept. 19
with Cincinnati Bengals' greats Ickey Woods, Solomon Wilcots, as well as other former and current NFL players; asthma testing provided by the American Lung Association; and food and beverages provided by Archer's Tavern. Other businesses interested in sponsoring the event can contact Travis Wilson at (440)
More news about: Pickleball Kingdom Centerville
Jul 14, 2026, 08:33 ET Anixa Biosciences Expands Global Patent Portfolio with Australian Patent Acceptance for Breast Cancer Vaccine Technology
breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. These vaccine technologies focus on immunizing against "retired" proteins that have been found to be expressed in certain forms
More news about: Anixa Biosciences, Inc.
Jul 14, 2026, 08:32 ET IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
cryoablation therapy systems for the destruction of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally invasive technology is a safe and effective option to surgical tumor removal that is easily performed in a relatively short procedure.
More news about: IceCure Medical